Hims & Hers Health HIMS-1.04%decrease; red down pointing triangle said it is now providing menopause care, marking the company’s latest push into hormone-replacement therapies. The telehealth company ...

Brown was the second university to turn down the deal, which would have given a funding preference to universities that agreed to certain requirements. By Alan Blinder Reporting from Providence, R.I.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — The German biotech Tubulis, which is designing a series of ...

Ghislaine Maxwell ’s unexpected arrival at a cushy Texas prison this August has left other inmates unsettled, with some claiming it seems that she receives preferential treatment, according to a ...

Jeremy Clarkson has praised the NHS following a hospital visit that occurred hours after calling the service a “creaking monster” that needed a “rethink”. The former Top Gear host has not revealed ...

Former president Joe Biden is taking a new approach to his battle with prostate cancer. “As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and ...

Every few weeks, a 65-year-old man named Rick drives an hour and a half from his home in New Hampshire to Brigham and Women’s Hospital in Boston, where a nurse inserts a needle in his arm and a clear ...

A new treatment for endometriosis is now available in New Zealand but it will set you back about $250 for a month's supply. Endometriosis is an inflammatory disease, with symptoms including period and ...

Top experts have developed new 'natural killer' cells to fight off cancer and lower the risk of disastrous immune effects. Researchers at Harvard Medical School and the Massachusetts Institute of ...

MAGA influencers are enraged after former FBI Director James Comey was able to use a back door for his first appearance in court. The former FBI director pleaded not guilty to two counts in the ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...